Literature DB >> 30416002

Quantitative Assessment of Tumor Cell Proliferation in Brain Gliomas with Dynamic Contrast-Enhanced MRI.

Jia Shen Jiang1, Ye Hua2, Xue Jun Zhou3, Dan Dan Shen4, Jin Long Shi5, Min Ge6, Qi Nan Geng7, Zhong Zheng Jia8.   

Abstract

RATIONALE AND
OBJECTIVES: This study aimed to investigate whether volume transfer constant (Ktrans) and volume of extravascular extracellular space per unit volume of tissue (Ve) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE MRI) could quantitatively assess the tumor proliferation index (Ki-67) of gliomas noninvasively.
MATERIALS AND METHODS: The preoperative DCE MRI data of 69 patients with pathologically confirmed glioma (28, 8, and 33 cases in grades Ⅱ, Ⅲ, and Ⅳ) were retrospectively reviewed. The maximal Ktrans and Ve were measured in the tumor body. The immunohistochemistry was used to detect the expression of Ki-67 proteins in glioma specimens. The Mann-Whitney U test was applied to analyze the differences in Ktrans, Ve, and Ki-67 index across histologically defined glioma grades. Spearman correlation was performed between Ktrans, Ve, and Ki-67 index. The receiver operating characteristic curve analysis was used to determine the cutoff values of Ktrans and Ve in distinguishing different Ki-67 index expression levels.
RESULTS: Ktrans, Ve, and Ki-67 index of grade Ⅱ (0.027 min-1, 0.065, 4.04%) were significantly lower than those of grade Ⅲ (0.093 min-1, 0.297, 25.13%) and Ⅳ (0.100 min-1, 0.299, 25.37%). Both Ktrans and Ve significantly correlated with the Ki-67 index in all tumors and high-grade gliomas (HGGs, grade Ⅲ and Ⅳ). The receiver operating characteristic curve analysis revealed that the cutoff values for Ktrans (0.079 min-1) and Ve (0.249) provided the best combination of sensitivity and specificity to distinguish the gliomas with high Ki-67 index from those with low Ki-67 index.
CONCLUSION: The DCE MRI-derived parameters were valuable in assessing the tumor cell proliferation in HGG noninvasively.
Copyright © 2018 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dynamic contrast-enhanced; Glioma; Ki-67; Magnetic resonance imaging

Year:  2018        PMID: 30416002     DOI: 10.1016/j.acra.2018.10.012

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  3 in total

1.  Do the combination of multiparametric MRI-based radiomics and selected blood inflammatory markers predict the grade and proliferation in glioma patients?

Authors:  Jing Guo; Jialiang Ren; Junkang Shen; Rui Cheng; Yexin He
Journal:  Diagn Interv Radiol       Date:  2021-05       Impact factor: 2.630

2.  Associations Between Dynamic Contrast Enhanced Magnetic Resonance Imaging and Clinically Relevant Histopathological Features in Breast Cancer: A Multicenter Analysis.

Authors:  Alexey Surov; Jin You Kim; Marco Aiello; Wei Huang; Thomas E Yankeelov; Andreas Wienke; Maciej Pech
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

3.  Reliability of dynamic contrast-enhanced magnetic resonance imaging data in primary brain tumours: a comparison of Tofts and shutter speed models.

Authors:  Marianna Inglese; Katherine L Ordidge; Lesley Honeyfield; Tara D Barwick; Eric O Aboagye; Adam D Waldman; Matthew Grech-Sollars
Journal:  Neuroradiology       Date:  2019-08-07       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.